About this trial

The goal of this multicentre observational study is to analyse the treatment strategies and the outcomes for patients with S. maltophilia infections using target trial emulation methodology. The main question it aims to answer is:

• Does combined therapy achieve better results than monotherapy in treating S. maltophilia infections?

Researchers will compare groups receiving monotherapy and combined therapy to see if there are differences in all-cause 30-day mortality.

Eligibility criteria

Qualifiers

Adult patients

S. maltophilia infections

Different episodes if a new infection ocurred > 30 days since the index episode

Disqualifiers

isolates obtained from patients outside of hospital admission

microbiological or clinical colonization

hospitalizations shorter than 72 hours since the time zero

patients who died in the first 72 hours since the time zero or who were in imminent risk of death

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

1
Microbiology and Infectious Disease Department, Hospital General Universitario Gregorio Marañón28007, MadridMadrid, Spain

Sponsors and collaborators

Instituto de Investigación Sanitaria Gregorio Marañón

Lead sponsor